Subclinical thyroid disease: where is the evidence?

Lancet Diabetes Endocrinol. 2013 Nov;1(3):172-3. doi: 10.1016/S2213-8587(13)70030-5. Epub 2013 May 23.

Authors

Jayne A Franklyn¹, Kristien Boelaert²

Affiliations

¹ Centre for Diabetes, Endocrinology and Metabolism, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK. Electronic address: j.a.franklyn@bham.ac.uk.
² Centre for Diabetes, Endocrinology and Metabolism, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.

PMID: 24622359
DOI: 10.1016/S2213-8587(13)70030-5

No abstract available

MeSH terms

Asymptomatic Diseases / epidemiology*
Asymptomatic Diseases / therapy
Cardiovascular Diseases / etiology*
Humans
Practice Patterns, Physicians' / trends*
Thyroid Diseases / complications*
Thyroid Diseases / drug therapy
Thyroid Diseases / epidemiology*
Thyroid Hormones / metabolism*

Substances

Thyroid Hormones

Grants and funding

G0601811/MRC_/Medical Research Council/United Kingdom